Pasithea Therapeutics (KTTA) EPS (Basic) (2021 - 2026)
Pasithea Therapeutics (KTTA) posted EPS (Basic) of -$0.12 for Q1 2026, up 91.8% sequentially from -$1.44 in Q4 2025, and up 92.68% YoY from -$0.06 in Q1 2025.
Pasithea Therapeutics (KTTA) EPS (Basic) (2021 - 2026) Analysis & Trends
Pasithea Therapeutics has reported EPS (Basic) for 6 years, with the latest figure at -$0.12 in Q1 2026.
- Quarterly EPS (Basic) rose 92.68% year-over-year to -$0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.81 (up 86.82% YoY) and the FY2025 annual result came in at -$2.91, up 77.1% from the prior year.
- EPS (Basic) improved to -$0.12 in Q1 2026 per KTTA's latest filing, from -$1.44 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.3 in Q3 2022 and troughed at -$3.71 in Q2 2024.
- A 5-year average of -$1.31 and a median of -$0.53 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) surged 108.73% in 2022, then slumped 4239.66% in 2024.
- Over 5 years, EPS (Basic) stood at -$2.71 in 2022, then soared by 97.53% to -$0.07 in 2023, then plunged by 4239.66% to -$2.9 in 2024, then soared by 50.4% to -$1.44 in 2025, then soared by 91.8% to -$0.12 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.12, -$1.44, and -$0.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Pasithea Therapeutics | 15.89 Mn | 15.89 Mn | - | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.12 |
| Dec 31, 2025 | -1.44 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -1.61 |
| Dec 31, 2024 | -2.90 |
| Sep 30, 2024 | -2.87 |
| Jun 30, 2024 | -3.71 |
| Mar 31, 2024 | -3.70 |
| Dec 31, 2023 | -0.07 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -2.71 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | -0.40 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | 1.21 |
| Sep 30, 2021 | -3.41 |
| Jun 30, 2021 | -1.76 |
| Mar 31, 2021 | -1.38 |